Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.

Dhanasekaran R, Sanchez W, Mounajjed T, Wiesner RH, Watt KD, Charlton MR. Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence. Liver Int. 2015 Nov; 35(11):2433-41.

View in: PubMed

subject areas

Adult
Antiviral Agents
Biopsy
Disease Progression
Drug Therapy, Combination
Female
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon-alpha
Kaplan-Meier Estimate
Liver
Liver Cirrhosis
Liver Transplantation
Male
Middle Aged
Multivariate Analysis
Polyethylene Glycols
Proportional Hazards Models
Recombinant Proteins
Recurrence
Retrospective Studies
Ribavirin
Survival Rate
Treatment Outcome
Viral Load

authors with profiles

Michael Charlton